scholarly article | Q13442814 |
P50 | author | Mary R Loeken | Q55459541 |
P2093 | author name string | Mary R Loeken | |
P2860 | cites work | Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation | Q38426687 |
Teratogen update: valproic acid | Q39596882 | ||
Etiology and pathogenesis of human neural tube defects: insights from mouse models. | Q40588782 | ||
A study of level of lesion, associated malformations and sib occurrence risks in spina bifida | Q40920970 | ||
Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy | Q44826641 | ||
Risk of neural tube defect-affected pregnancies among obese women | Q46340446 | ||
Maternal obesity and risk for birth defects | Q47937598 | ||
Glucose transporter gene expression in early mouse embryos | Q48212878 | ||
Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. | Q54067304 | ||
The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida. | Q55042537 | ||
Spectrum of congenital anomalies in pregnancies with pregestational diabetes | Q57077336 | ||
Possible interaction of genotypes at cystathionine β-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects | Q57624031 | ||
Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats | Q68443220 | ||
Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy | Q74661124 | ||
GLUT2 is a high affinity glucosamine transporter | Q28215692 | ||
Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy | Q28284049 | ||
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity | Q28303894 | ||
The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy | Q28730838 | ||
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels | Q29547214 | ||
Genetic studies in neural tube defects. NTD Collaborative Group | Q33891734 | ||
Mouse models for neural tube closure defects | Q33892671 | ||
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks | Q34301257 | ||
Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies | Q34360980 | ||
Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. | Q34395378 | ||
Hyperglycemia and adverse pregnancy outcomes | Q34777029 | ||
Diabetes mellitus and birth defects | Q34803469 | ||
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from | Q34876993 | ||
Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects | Q35384441 | ||
Whole genomewide linkage screen for neural tube defects reveals regions of interest on chromosomes 7 and 10. | Q35447477 | ||
Neural tube closure and neural tube defects: studies in animal models reveal known knowns and known unknowns | Q36087230 | ||
The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities | Q36463221 | ||
Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study | Q36606588 | ||
Mouse embryonic stem cells established in physiological-glucose media express the high KM Glut2 glucose transporter expressed by normal embryos | Q37344264 | ||
Understanding diabetic teratogenesis: where are we now and where are we going? | Q37349983 | ||
Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy | Q37403195 | ||
Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. | Q38114717 | ||
P433 | issue | 4 | |
P921 | main subject | neural tube defect | Q548213 |
metabolic trait | Q113000858 | ||
P304 | page(s) | 415-417 | |
P577 | publication date | 2014-01-25 | |
P1433 | published in | Molecular Genetics and Metabolism | Q6895949 |
P1476 | title | Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks | |
P478 | volume | 111 |
Search more.